Tag: Ocala

Talcum Powder Lawyers Win | Talc Lawsuit Alert

Talcum Powder Lawyers Win For Ovarian Cancer Victim

J&J  Has Been Ordered to Pay $417 Million

(Reuters) – A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company’s talc-based products like Johnson’s Baby Powder for feminine hygiene.
The Los Angeles Superior Court jury’s verdict in favor of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of its talc-based products.
“We are grateful for the jury’s verdict on this matter and that Eva Echeverria was able to have her day in court,” Mark Robinson, her lawyer, said in a statement.
The verdict included $70 million in compensatory damages and $347 million in punitive damages. It was a major setback for J&J, which faces 4,800 similar claims nationally and has been hit with over $300 million in verdicts by juries in Missouri.
“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” J&J said.
Echeverria’s lawsuit was the first out of hundreds of California talc cases to go to trial.
The 63-year-old claimed she developed terminal ovarian cancer after decades of using J&J’s products. Her lawyers argued J&J encouraged women to use its products despite knowing of studies linking ovarian cancer to genital talc use.
J&J’s lawyers countered that studies and federal agencies have not found that talc products are carcinogenic.
The trial follows five prior ones in Missouri state court, where many lawsuits are pending.
J&J lost four of those trials and, along with a talc supplier, has been hit with $307 million in verdicts. Before Monday, the largest verdict was for $110 million.
The Missouri cases, which have largely been brought by out-of-state plaintiffs, have faced jurisdictional questions after the U.S. Supreme Court issued a ruling in June that limited where personal injury lawsuits can be filed.
In a decision in a case involving Bristol-Myers Squibb Co, the Supreme Court said state courts cannot hear claims against companies that are not based in the state when the alleged injuries did not occur there.
The ruling prompted a St. Louis judge, at New Jersey-based J&J’s urging, to declare a mistrial in the talc case already underway.
The judge has nonetheless left the door open for the plaintiffs to argue they still have jurisdiction based on a Missouri-based bottler J&J used to package its products.
The case is Echeverria et al v. Johnson & Johnson, Los Angeles Superior Court, No. BC628228.
(Reporting by Nate Raymond in Boston; Editing by Matthew Lewis and Paul Simao)

If you or a loved one used  Johnson and Johnson Talcum Powder  products for over five years on or near the genital area and now have a diagnosis of ovarian cancer or fallopian tube cancer contact The Talcum Powder Lawyer Helpline today.

Talcum Powder Cancer Lawsuits Continue

Johnson and Johnson Facing Potentially  1000’s Of Ovarian Cancer Lawsuits

Johnson and Johnson won a  fourth talcum powder lawsuit but, had  three judgements of $72 million, $70 million and $55 million. Our lawyers have filed dozens of talcum powder lawsuits  on behalf of women who claim they got  ovarian cancer from Johnson & Johnson’s talcum based powders. A fifth talcum baby powder lawsuit was heard in the 22nd Circuit Court in St. Louis, Missouri, on April 10th. The jury heard the case of Lois Slemp, who alleges that she developed ovarian cancer as a result of long term use of talc powder found in feminine hygiene products made by Johnson & Johnson (J&J).

A California state court judge will convene a 5-day “Sargon” hearing, California’s equivalent of a Daubert proceeding, to determine the admissibility of expert witness testimony. This could be as significant as a trial itself, after a New Jersey state court judge in October nixed testimony from two key expert witnesses for the plaintiff, scuttling what was set to the first talcum powder trial in the state. That decision remains on appeal.

Depending on the outcome of the June hearing, a bellwether trial is scheduled for July in Los Angeles, along with another trial scheduled that same month in Washington D.C. Superior Court. .

The case is captioned Valerie Swann, et al. v. Johnson & Johnson, et al. case number 1422 CC09326-01 in Missouri’s 22nd Judicial Circuit Court.

Talcum powder cases continue in Federal court. About 134 cases are on file in the District of New Jersey Federal Court. The parties have been discussing various topics, including a protective order, a preservation order and other legal issues. A preservation order is where a plaintiff has to store physical or biological evidence for use in trials.

Johnson & Johnson reported in a recent filing with the U.S. Securities & Exchange Commission (SEC) that it has been named a defendant in at least 3,100 product liability claims. These lawsuits are claims by women that Baby Powder and Shower-to-Shower talc-based powders contributed to them getting ovarian cancer.

If you think you have a diagnosis of ovarian cancer due to your use of Baby Powder or Shower To Shower contact us today

 

Woman Wins Big On Talcum Powder Ovarian Cancer Claim

A Jury Granted More Than $70M In A J&J Baby Powder  Ovarian Cancer Lawsuit.

A California woman has been awarded more than $70 million  in a claim that Johnson and Johnson’s baby powder gave  her ovarian cancer.

“We are pleased the jury did the right thing. They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product,” Jim Onder, an attorney for the plaintiff, advised The Associated Press.

“We deeply sympathize with the women and families impacted by ovarian cancer,” Carol Goodrich, a spokeswoman with Johnson & Johnson, said in a statement. “We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”

Is Baby Powder Safe?

It is now known that use of talc products can  increase a women’s risk of ovarian cancer.

The International Agency for Research on Cancer advises that the product is “possibly carcinogenic.” The National Toxicology Program, made up of parts of a few distinctive government organizations, has not completely inspected talc.

 

 

Alternatives To Talcum Powder

Talcum Powder Lawsuit Helpline continues to get calls on a daily basis from women with a diagnosis of ovarian cancer seeking a Talcum Powder lawyer. The Talcum Powder Lawsuit Helpline offers the latest news on Talcum Powder and the Talc Lawsuits. We found this article online about alternatives to talcum powder and think it will be helpful to our readers.

What Are The Alternatives To Talcum Powder?

Not all medical professionals agree that a link between baby powder and ovarian cancer exists.
The recent headlines about baby powder and its connection to ovarian cancer may raise more questions than answers. In February, a Missouri court ordered Johnson & Johnson to pay $72 million in damages to the family of Jackie Fox, a woman who died of ovarian cancer. The lawsuit said her death was linked to her 50-year daily habit of applying baby powder. But Johnson & Johnson insisted a correlation between talc powder and ovarian cancer has not been proven.

“The verdict goes against decades of sound science proving the safety of talc as a cosmetic ingredient in multiple products, and while we sympathize with the family of the plaintiff, we strongly disagree with the outcome,” a spokesman for the company said in a statement.

Prosecutors say Johnson & Johnson knew about the risk since the early 1980s and did not protect its customers. In fact, the first study conducted on talc powder use on female genitalia found a 92 percent increased risk for ovarian cancer with women who reported genital talc use. But still, other doctors disagree. “Several decades of medical research do not support the hypothesis that use of talcum powder causes ovarian cancer,” said Dr. Hal Lawrence, chief executive officer of the American Congress of Obstetricians and Gynecologists.

If all this back-and-forth has you questioning your baby powder usage, fear not. There are some safe alternatives to talc powder:

Cornstarch. Found in the baking aisle of your local grocery store, cornstarch is a great natural alternative to talc. The consistency is exactly the same, so it’ll help soak up wetness just as well. Cornstarch is derived from the endosperm of a corn kernel and is often used to help thicken sauces.

Arrowroot starch or tapioca starch. Both staples in a paleo baker’s kitchen, these starches are all-natural alternatives to talc. Arrowroot is derived from several tropical South American plants. Tapioca starch is derived from the crushed-up pulp of the South American cassava plant, a woody shrub. Both are used in paleo recipes as alternatives to flour and cornstarch. If you’re using it to on your baby’s sore bottom, try this recipe with some extra ingredients to help soothe.

Baking soda. You thought sodium bicarbonate, otherwise known as baking soda, only had 100 uses. Well, here’s one more: This common pantry item can be used in place of baby powder. Some people even use it as deodorant, applying some to their underarms each morning. It can also deodorize the air. As a matter of fact, I keep one container in my pantry, one under my sink, one in my laundry room and one in the bathroom.

Oat flour. Try this if you’re looking for a slightly coarser powder than the ones mentioned above.

Commercial baby powder alternatives. These products combine the items listed above with essential oils, so the powder smells pretty nice. Just to name a few:

Burt’s Bee’s Baby Dusting Powder
Honeybee Gardens Deodorant Powder
The Honest Company Organic Baby Powder
Nature’s Baby Dusting Powder
Here’s one last reason to consider the all-natural route: Talc is poisonous when inhaled or swallowed. It can cause breathing problems, which is why the American Academy of Pediatrics urges caution when it comes to using talc powder on babies.

If you or a loved one has a diagnosis of ovarian cancer and you or they have used Talcum Powder to dry off around the genital areas for over five years it would be in your best interest to call the Talcum Powder Lawsuit Helpline and speak to one of our talcum powder lawyers

Talcum Powder Lawsuit Consolidation Update

The Talcum Powder Lawsuit Helpline keeps you updated on all the latest news on the Talcum Powder lawsuits. We have just found out that the Talcum Powder Victims  in Illinois Class Action Will  Oppose Creation of An MDL Docket.

An MDL consolidates all nationwide Talcum Powder Lawsuits in one location under one judge in a court district, The idea of an MDL is to make the litigation process easier.

Plaintiffs involved in the Talcum Powder  lawsuits  pending in Illinois federal court will oppose the recent motion to create a multi-district litigation docket for talcum powder claims. Very often an MDL moves closer to a settlement offer from the manufacturer. It is possible that the lawyers  feel the will have better luck keeping the litigation at a local level.

According to an Aug. 1 docket entry entered in the U.S. District Court for the Southern District of Illinois, a status conference was held  and a motion had been filed to transfer this case into an MDL.

The Plaintiffs will be opposing the motion.

 

Talcum Powder Lawsuits Headed For Consolidation- MDL Status

It looks like the Talcum Powder lawsuits will be consolidated in a multi District litigation. A Multi District Litigation results in  all the ovarian cancer  lawsuits under one judge in one jurisdiction. The Talcum Powder Lawsuit Helpline continues to keep you updated on the progress of the Talcum Powder Lawsuits.
There have been more than 1,200 talcum powder ovarian cancer lawsuits  filed against Johnson & Johnson in state and federal courts.

A talcum powder lawsuit motion has been filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) seeking  to  consolidate  all  ovarian cancer lawsuits  in a single court, under one judge  in order to coordinate pretrial proceedings and make the process easier.  The chosen venue  suggested is the  U.S. District Court, Southern District of Illinois.

The motion claims  that the current ovarian cancer  plaintiffs reside in several different states and that the Southern District of Illinois would permit convenient travel for the parties and counsel.

Talcum Powder Lawsuit Helpline is reaching out to women who were diagnosed with ovarian cancer following years of regular, repeated use of talcum powder  products for feminine hygiene purposes.

Talcum Powder Ovarian Cancer Lawsuits

All of the talcum powder lawsuits have one thing in common. They claim that regular repeated and long term use  of Johnson & Johnson’s Baby Powder and Shower-to-Shower products to the genital area  can increase a woman’s risk of being  diagnosed with  ovarian cancer. All the lawsuits  claim  that talc particles can make their way into the vagina and migrate to the ovaries.  The accumulation of talc particles and the constant irritation and inflammation  can promote the growth of cancer cells. A number of studies published since the 1970s have suggested  a link.   Johnson & Johnson has failed to take any steps to warn women of this possible risk and link between Talc products and ovarian cancer.

More than 1,200 talcum powder lawsuits have been filed against Johnson & Johnson nationwide.   In April, a St. Louis jury awarded $55 million  to an ovarian cancer victim who used Johnson & Johnson’s talc-based powders for nearly 40 years  for  feminine hygiene . In February, another Missouri trial  resulted in  an award of $72 million for the family of a woman who died from ovarian cancer  after using talc products for more than 30 years.

Talcum Powder Lawsuit Helpline

Women who were diagnosed with ovarian cancer are calling us for help on a daily basis. They all have one thing in common, They have been diagnosed with ovarian cancer and have used  talc-based products for feminine hygiene for years. They are angry and want to speak to a Talcum Powder lawyer.

The Talcum Powder Lawsuit Helpline is  A nationwide resource for women who have used Talcum powder for personal hygiene and have concerns. Many have a diagnosis of ovarian cancer.   The Network of Talcum Powder Lawsuit attorneys have years of experience  representing women whio have been injured by a wide variety of dangerous drugs and devices. They have represented these women in complex individual and class action lawsuits against pharmaceutical and medical device companies.

 

Ovarian Cancer? Is Talcum Powder The New Culprit?

Cervical, Ovarian, Uterine, Vaginal, Vulvar cancer are various types of gynecological cancers women must be made aware of. You must understand your risk factors and the various products on the market that can potentially cause these types of cancer. These cannot be ignored nor can the potential risk of your having used talcum powder for years.
Recently Johnson and Johnson paid  72 million dollars  to a woman’s family after she passed away from ovarian cancer. The jury accepted the claim that the  woman’s use of talcum powder products for feminine hygiene caused for her ovarian cancer and  eventual death. There are no warning  labels on Johnson and Johnson’s Baby Powder or Shower to Shower that their  these products may be harmful to women if used this way.
This is not a new idea but women have been shocked and are frightened now. If you feel ashamed talking about your private parts then realize these manufacturers used your fear of not smelling fresh to sell this product and  never told you about the ovarian cancer risk.  It has been reported that over 98,000 women have been  diagnosed with gynecologic cancers last year. Many of these were due to ovarian cancer and we do not know how many of them used the “stay dry” talcum powder marketed to them.

Do you still use talcum powder for personal hygiene?  How many other products do you use that you have no clue may harm you? The manufacturers certainly did not fess up and you obviously cannot trust them to tell you.
After the Johnson and Johnson fiasco I realized how many dangerous drugs and devices that are massive lawsuits have targeted women. We speak to women every day about the potential risk of using talcum powder and people who have lost a loved one to ovarian cancer and now realize their mother, sister grandmother, wife or loved one used these products right where the particles can travel to the ovaries.

The more I  speak with callers about their ovarian cancer and their use of talcum powder products the more I realize how careful we must be and how glad I am my mother pushed old fashioned corn starch. It was also alot cheaper in those days. But, J & J found a great market to go after. The black and Hispanic women who wanted to fit into a white society and smell clean and nice became the ultimate target.  They knew  that choosing their product, if marketed correctly, had very little to do with awareness of cancer  health, and  totally due to  fear of not smelling like a pretty white princess  all day and  every day.

Black woman often  used talcum powder  for her  their entire adult life. These products seemed safe, after all, mothers used talcum powder on their babies, right? Using Talcum Powder products were a part of being in with the other girls. Yet, as far back as 2005 Fred Hutchinson Cancer Research Center did a study  about these products. Another study   was published in 1997. The studies suggested  there might  be a connection between talcum powder use  and ovarian cancer.
Now we learn the truth thru Talcum Powder Lawsuit  TV lawyer ads.
Is there is a  connection between feminine hygiene powders and ovarian cancer? It seems that biopsies are finding talc particles in the ovaries and these particles may have been there for years. It has been noted that the constant irritation can lead to cancer producing cells. The news is out now. The Johnson and Johnson lawsuit has awakened women  across the  country. They are calling us everyday and the families that lost them to ovarian cancer are calling as well. Do you believe your ovarian cancer diagnosis is from your use of Talcum Powder? Did you lose a loved one to ovarian cancer? Did she use talcum powder daily to keep dry? Do you want to join others in the Talcum Powder lawsuit and send a message to get those bad products off the shelves? Call the Talcum Powder Lawsuit Helpline..

Talcum Powder- Ovarian Cancer Helpline

The Talcum Powder Lawsuit Helpline has Talcum Powder lawyers filing Talcum Powder lawsuits for women who have gotten ovarian cancer from Talcum Powder. The Talcum Powder Lawsuit Helpline continues to report any recent news regarding the lawsuits and research regarding ovarian cancer. Ovarian cancer is a serious and often fatal disease and we are constantly on the look out for new and important updates that may be of interest to our followers.

We found this article and thought it might be helpful to women. This article discusses some ways to make it easier to find out if you have or are at risk for ovarian cancer.

Testing the  DNA  of a woman should identify the most effective drugs and finds out if other family members are at risk.

Fewer than a third of patients are currently tested, but the team at the Institute of Cancer Research (ICR) in London made it easier for women and increased uptake to 100%.

Experts said the findings were an important step.

The focus of testing is a set of genetic mutations which run in families called BRCA – they cause 15% of the 7,100 ovarian cancers detected in the UK each year.

Knowing if the patient is in the 15% helps improve treatment as some chemotherapy drugs are more effective against tumours caused by BRCA mutations.

And cancer drugs such as PARP inhibitors work only in women with BRCA mutations.

A tumour that is positive for BRCA is also an early warning to other family members that they may be at risk of developing ovarian, breast or prostate cancers.

‘Excellent example’
Testing currently involves getting an appointment with a separate genetics team after being diagnosed by a cancer doctor. The average wait is 12-15 weeks, the researchers say, and only a minority of women go for it.

The ICR team used advances in genetics testing – which is getting faster and cheaper – to offer screening with the original cancer doctor.

Prof Nazneen Rahman, who led the trial, told the BBC News website: “It cuts off all that time on a waiting list and extra consultation. The feedback from patients has been overwhelmingly positive.”

The results of the trial, published in the journal Scientific Reports, showed all patients had screening and got their results in a quarter of the time. It also estimated the National Health Service would save £2.6m a year if it changed the way testing was offered.

Prof Rahman added: “There would be 283 fewer cancers and 77 fewer deaths a year – it really does save lives and money.

“It’s very unusual to get a win-win all round that allows us to help more people but doesn’t cost more.”

It is likely the approach would also work for other cancers, such as those in the breast.

Prof Paul Workman, the chief executive of ICR, said: “Twenty years ago the BRCA2 gene was identified at the ICR. This study is an excellent example of how science such as this can be turned into something very practical that can improve the patient care and save lives. We hope the new model for genetic testing will be rolled out across the NHS.”

Alexandra Holden, from the charity Target Ovarian Cancer, commented: “Any improved access to genetic testing for all women with ovarian cancer is an important step.

“It is essential that all women with ovarian cancer get genetic counseling, as we know from the women with ovarian cancer we support that there can be numerous, complex implications of a test, for all the family.”

Taxotere Hair Loss Lawyers | Taxotere Helpline Announced

In continuing to maintain it’s role in helping women injured by dangerous drugs, devices and consumer products the Helpline ” Pink Sites” has launched a Taxotere Helpline and outreach campaign to locate all women effected by permanent hair loss after using Taxotere.

Taxotere Lawyers Filing  Hair Loss Lawsuits

In a recent Taxotere lawsuit a  woman  alleged that her use of breast cancer drug Taxotere (docetaxel) resulted in permanent alopecia, or a total failure of her hair to regrow. Sanofi-Aventis has  failed to warn patients that they may not experience hair regrowth after stopping Taxotere.

 

Taxotere Lawsuits Mount Up
In December of 2015, the U.S. Food and Drug Administration publicly announced  numerous adverse incident  reports related to Taxotere and permanent alopecia in breast cancer chemotherapy patients.

If these  filings continue  Taxotere cases may be  consolidated in federal multidistrict litigation (MDL)

 

Latest Research on Ovarian Cancer

The Talcum Powder Lawsuit Helpline is more then just a network of experienced Talcum Powder Lawsuit Attorneys. We offer ovarian cancer resources and updates that are found online. Below you will find some of the latest research on ovarian cancer. It is now known, that the manufacturers knew that there was a potential link between ovarian cancer and the use of Talcum Powder and Baby Powder. The jury knew it when they gave the family of a talcum powder- ovarian cancer victim $72 million.

We found this page on the latest research and offer it to our followers. We hope this helps.

Ovarian Cancer – Latest Research
Approved by the Cancer.Net Editorial Board, 04/2015

Doctors are working to learn more about ovarian cancer, ways to prevent it, how to best treat it, and how to provide the best care to people diagnosed with this disease. The following areas of research may include new options for patients through clinical trials. Always talk with your doctor about the diagnostic and treatment options best for you.

Screening For Ovarian Cancer

There are no currently effective screening methods for the general population. A screening method that estimates a woman’s risk of ovarian cancer by using her age and the results of a yearly CA-125 blood test holds promise for detecting early-stage ovarian cancer. An international study is looking into the role of serial CA-125 screening for ovarian cancer. As explained in Diagnosis, CA-125 is a substance called a tumor marker that is found in higher levels in women with ovarian cancer.

In 2012, the U.S Preventative Services Task Force released a statement saying that for the general population of women with no symptoms, screening for ovarian cancer is not helpful and may lead to harm. However, women at high risk for ovarian cancer due to family history or with a BRCA mutation(s) (see Risk Factors) are recommended to have screening with CA-125 blood tests and transvaginal ultrasound. This approach has not been proven to improve survival or detect cancers at an earlier and more curable stage.

Targeted Therapy For Ovarian Cancer

Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival.

Some targeted therapy is directed towards specific genes that might be found with abnormalities in certain types of epithelial ovarian cancer. For this purpose, ovarian cancer is divided into two groups:  type I and type II.  Type II cancers are the more typical high grade serous cancers, for which standard chemotherapy has been most effective. These tumors typically are diagnosed at later stages and have mutations in TP53 and BRCA genes in the tumor.  Other mutations are rarely seen.

The BRCA mutation, even if only found in the tumor and not in the blood, may increase the effectiveness of a certain classes of drugs such as PARP inhibitors (see below).  Type I tumors include the more rare types of ovarian cancer including low grade serous, endometrioid, clear cell, and mucinous cancers.  These tumors have a variety of mutations including KRAS, BRAF, PI3KCA and PTEN, which have implications for targeted treatment. Clinical trials in these groups are ongoing.

Anti-Angiogenesis Inhibitors For Ovarian Cancer

Drugs called anti-angiogenesis inhibitors block the action of a protein called vascular endothelial growth factor (VEGF). These drugs have been shown to increase the cancer’s response to treatment and delay the time it takes for the cancer to return. VEGF promotes angiogenesis, which is the formation of new blood vessels. Because a tumor needs nutrients delivered by blood vessels to grow and spread, the goal of anti-angiogensis therapies is to “starve” the tumor. Bevacizumab (Avastin), an antibody which binds VEGF and prevents it from being active, has been shown to be effective in ovarian cancer.  FDA approval was recently given in the United States for its use in combination with selected chemotherapy for patients with platinum resistant recurrence.
PARP Inhibitors For Ovarian Cancer

Another class of drugs, called PARP inhibitors, are being evaluated for ovarian cancer.  These drugs act on DNA repair in cancer cells, making it difficult for them to replicate.  The BRCA genes (BRCA1 and BRCA2) are also normally involved in DNA repair, and a mutation in these genes interfere with this pathway function.  PARP inhibitors make it particularly difficult for cells that otherwise have a BRCA mutation to grow and divide.

The PARP inhibitor olaparib (Lynparza) has received FDA approval in the United States for recurrent disease in patients who have the inherited BRCA mutation and who have received three or more lines of chemotherapy.  In the supporting study of 137 patients with a BRCA mutation, 34% of patients experienced shrinkage in tumor for an average of 7.9 months. A very small number of patients developed secondary hematologic (blood) cancers after use of these drugs. Studies are currently underway with other PARP inhibitors, which do not all require the inherited BRCA mutation. These are being tested to see if they can keep the cancer from coming back after chemotherapy. The potential benefits and risks of PARP therapy should be discussed with your doctor.
Many other new targeted treatments are also now in clinical trials. Increasingly, doctors are learning about each patient’s individual tumor’s biology through direct molecular testing. This information may be useful in matching patients with a clinical trial for a specific targeted therapy.  Learn more about the basics of targeted therapy.

Immunotherapy For Ovarian Cancer

Immunotherapy is usually designed to boost the body’s natural defenses to fight the cancer. It uses materials made either by the body or in a laboratory to bolster, target, or restore immune system function. Researchers are currently examining whether drugs called checkpoint inhibitors may boost the immune system’s ability to destroy cancer cells.  Examples of these drugs target CTLA4 or PD-1 and have recently been shown to cause shrinkage in other cancer types such as melanoma, as well as having some activity in patients with ovarian cancer.

Cancer vaccines are another type of immunotherapy currently being tested for ovarian cancer.  In addition, some approaches called “adoptive cell therapy” take killer T cells found as part of the immune system in an individual patient and grow them in the laboratory, train them to attack certain targets such as MUC 16 (CA125) that is found on any ovarian cancer cells, and them give them back intravenously to the patient.  This approach has been tried in patients with hematologic cancers using other targets with some early success, and clinical trials are now opening for ovarian cancer.  Learn more about the basics of immunotherapy.

Hormone Therapy For Ovarian Cancer

Research is underway about the role of estrogen, androgens, and other hormones in ovarian cancer treatment. For treatment of recurrent or later-stage ovarian cancer,  the use of tamoxifen (Nolvadex, Soltamax), aromatase inhibitors, and enzalutamide (Xtandi), a blocker of the androgen receptor, is being considered.

Gene Therapy For Ovarian Cancer

One new area of research is discovering how damaged genes in ovarian cancer cells can be corrected or replaced. Researchers are studying the use of specially designed viruses that carry normal genes into the core of cancer cells and then replace the defective genes with the functional ones.

Supportive Care For Ovarian Cancer

Clinical trials are underway to find better ways of reducing symptoms and side effects of current ovarian cancer treatments, in order to improve a woman’s comfort and quality of life.

We will continue to search the net for ovarian cancer  information to help our clients. Our goal is to offer information that may help